
Incorporating PROs into clinical trials
Course InformationAllison Camp, PhD provides an overview of INDs: what they are, when they are needed, what is required for their preparation and submission, and how they are maintained with the FDA. This topic is discussed with the help of past LCCC examples. Learning Objectives
|
Course RegistrationPlease contact us with any questions at [email protected] or (919) 445–1000. DisclaimerThe views expressed herein are those of the presenter, they do not necessarily reflect the views of the contracted organization, department, School of Medicine, nor the University of North Carolina at Chapel Hill. |
![]() | Oncology Clinical Trials Series The Oncology Clinical Trials series, developed by Claire Dees, MD, ScM, provides an introduction to clinical research in oncology, with a focus on the design and conduct of clinical trials. Topics include trial design, implementation, regulatory and ethical considerations, data management, and common challenges in oncology research. The series also introduces complementary areas such as biomarkers, correlative studies, and other approaches that support therapeutic trials, along with considerations for career development in clinical research. This series is designed for fellows, faculty, and oncology advanced practice providers (APPs) across cancer-related disciplines, including medical, hematologic, gynecologic, urologic, head and neck, pediatric, surgical, and radiation oncology. |
![]() | Matthew LeBlanc, PhD, RN Assistant Professor |
Available Credit
- 1.00 Participation

Facebook
X
LinkedIn
Forward
